138 related articles for article (PubMed ID: 8575032)
1. Development of potent serotonin-3 (5-HT3) receptor antagonists. II. Structrue-activity relationships of N-(1-benzyl-4-methylhexahydro-1H-1,4- diazepin-6-yl)carboxamides.
Harada H; Morie T; Hirokawa Y; Terauchi H; Fujiwara I; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1912-30. PubMed ID: 8575032
[TBL] [Abstract][Full Text] [Related]
2. Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-chlorobenzamide derivatives.
Harada H; Morie T; Hirokawa Y; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1364-78. PubMed ID: 7553982
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
5. Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Marubayashi N; Sano M; Kanzaki K; Inaba K; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2051-60. PubMed ID: 8945770
[TBL] [Abstract][Full Text] [Related]
6. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Clark R; Whiting RL; Hegde SS
Br J Pharmacol; 1995 Feb; 114(4):860-6. PubMed ID: 7773547
[TBL] [Abstract][Full Text] [Related]
8. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. II. Synthesis and structure-activity relationships of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
Ohta M; Suzuki T; Ohmori J; Koide T; Matsuhisa A; Furuya T; Miyata K; Yanagisawa I
Chem Pharm Bull (Tokyo); 1996 May; 44(5):1000-8. PubMed ID: 8689715
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Sakamori M; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents.
Kato S; Fujiwara I; Yoshida N
Med Res Rev; 1999 Jan; 19(1):25-73. PubMed ID: 9918193
[TBL] [Abstract][Full Text] [Related]
11. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. I. Synthesis and structure-activity relationships of conformationally restricted fused imidazole derivatives.
Ohta M; Suzuki T; Koide T; Matsuhisa A; Furuya T; Miyata K; Yanagisawa I
Chem Pharm Bull (Tokyo); 1996 May; 44(5):991-9. PubMed ID: 8689729
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
[TBL] [Abstract][Full Text] [Related]
14. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
15. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
Ohta M; Suzuki T; Furuya T; Kurihara H; Tokunaga T; Miyata K; Yanagisawa I
Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1707-16. PubMed ID: 8855365
[TBL] [Abstract][Full Text] [Related]
16. New 5-HT3 (serotonin-3) receptor antagonists. V. Synthesis and structure-activity relationships of pyrrolo[2,1-c][1,4]benzoxazine-6-carboxamides.
Kato M; Nishino S; Ito K; Yamakuni H; Takasugi H
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1358-63. PubMed ID: 7553981
[TBL] [Abstract][Full Text] [Related]
17. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
18. Evidence that 5-HT3 receptors in the nucleus tractus solitarius and other brainstem areas modulate the vagal bradycardia evoked by activation of the von Bezold-Jarisch reflex in the anesthetized rat.
Pires JG; Silva SR; Ramage AG; Futuro-Neto HA
Brain Res; 1998 Apr; 791(1-2):229-34. PubMed ID: 9593908
[TBL] [Abstract][Full Text] [Related]
19. New 5-HT3 (serotonin-3) receptor antagonists. IV. Synthesis and structure-activity relationships of azabicycloalkaneacetamide derivatives.
Kato M; Ito K; Nishino S; Yamakuni H; Takasugi H
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1351-7. PubMed ID: 7553980
[TBL] [Abstract][Full Text] [Related]
20. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
Yamano M; Ito H; Kamato T; Miyata K
Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
